Pediatric empyemas – Has the pendulum swung too far?

Analysis of treatment trends for pediatric empyema from 2010-2017 shows a dramatic decline in primary VATS use (from 40% to <10%) while rescue VATS rates remained consistently low (4-9%). This shift suggests increasing preference for conservative management with chest tubes and fibrinolytics as first-line therapy.